Huadong Medicine Co., Ltd (SHE: 000963)

Market Cap	60.96B
Revenue (ttm)	41.71B
Net Income (ttm)	3.21B
Shares Out	1.75B
EPS (ttm)	1.83
PE Ratio	18.99
Forward PE	19.92
Dividend	0.70 (1.98%)
Ex-Dividend Date	Sep 20, 2024

Volume	4,197,233
Open	36.30
Previous Close	36.38
Day's Range	36.02 - 36.50
52-Week Range	25.96 - 42.30
Beta	0.67
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 25, 2024

About Huadong Medicine

Huadong Medicine Co., Ltd produces and sells various pharmaceutical products in China. It also engages in the production and management of traditional Chinese and western raw medicines and preparations, and health care products; wholesale of TCM materials, TCM decoction pieces, chemical preparations, etc.; warehousing and storage business; and research, development, production, and sale of aesthetic medicine products. Huadong Medicine Co., Ltd was founded in 1993 and is headquartered in Hangzhou, China.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1993
• Employees: 16,969
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 000963

Financial Performance

In 2023, Huadong Medicine's revenue was 40.62 billion, an increase of 7.71% compared to the previous year's 37.71 billion. Earnings were 2.84 billion, an increase of 13.59%.